Trials / Unknown
UnknownNCT02528552
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Theradome, Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective, randomized double-blind, multi-center study to evaluate the efficacy of low level laser therapy over-the-counter at home device Theradome LH80 PRO, compared to SHAM for promoting hair growth in males diagnosed with androgenetic alopecia, and a usability study to assess subject ability to self-assess hair loss and understanding use of the device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LH80 PRO | |
| DEVICE | Sham Device |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-10-01
- Completion
- 2016-12-01
- First posted
- 2015-08-19
- Last updated
- 2016-12-02
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02528552. Inclusion in this directory is not an endorsement.